Eva Tomiak
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, BRCA gene mutations in cancer, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies
Most-Cited Works
- → Adjuvant Docetaxel for Node-Positive Breast Cancer(2005)951 cited
- → Breast-Cancer Risk in Families with Mutations in PALB2(2014)845 cited
- → Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy(1999)506 cited
- → Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type(2014)493 cited
- → Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study(2003)228 cited
- → A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer(2006)224 cited
- → Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes(2013)172 cited
- → The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study(2007)156 cited
- → Estimates of the lifetime costs of breast cancer treatment in Canada(2000)148 cited
- → Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.(1994)132 cited